FDA Approves Fetzima for the Treatment of Depression

On July 26, 2013 the FDA announced its approval of a new antidepressant medication called Fetzima (levomilnacipran extended-release capsules) for the treatment of Major Depressive Disorder (MDD) in adults. It is not yet, however, approved for the treatment of fibromyalgia pain....Read Full Post
Source: About.com Depression - Category: Psychiatry Source Type: news